Insomnia Pipeline Review H1 2017 Pharmaceutical and Healthcare latest pipeline guide provides comprehensive information on the therapeutics under development for Insomnia (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Inquire for Complete Insomnia - Pipeline Review, H1 2017 Report at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1010752

Insomnia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Insomnia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 2, 10, 4, 9 and 4 respectively. Similarly, the Universities portfolio in Phase I and Preclinical stages comprises 1 and 3 molecules, respectively. This report reviews key companies involved in Insomnia (Central Nervous System) therapeutics and enlists all their major and minor projects.

Companies Discussed Actelion Ltd, Alexza Pharmaceuticals Inc, Athenex Inc, Eisai Co Ltd, Evotec AG, Grupo Ferrer Internacional SA, Heptares Therapeutics Ltd, Intec Pharma ltd, Intra-Cellular Therapies Inc, Johnson & Johnson, Leading BioSciences Inc, Merck & Co Inc, Neurim Pharmaceuticals Ltd, Novartis AG, Reviva Pharmaceuticals Inc, Shionogi & Co Ltd, Taisho Pharmaceutical Co Ltd, Takeda Pharmaceutical Company Ltd, Yangtze River Pharmaceutical Group

To Get Discount on This Report Visit: http://www.reportsnreports.com/contacts/discount.aspx?name=1010752 (This report is available at up to 25% Discount till June 02nd 2017.)
Insomnia pipeline guide features descriptive drug profiles for the pipeline products which comprise product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

Insomnia drug profiles Discussed (diphenhydramine + lorazepam + zolpidem tartrate), CB-2810, CY-18, CY-20, DORA-12, EVT-201, HTL-6641, JNJ-48816274, JNJ-7922, LASSBio-785, LASSBio-786, lemborexant, lorediplon, lumateperone tosylate, MK-8133, MLS-03, nebivolol, NEO-1940, piromelatine, ramelteon, S-117957

Insomnia pipeline report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Direct Purchase This Report at http://www.reportsnreports.com/purchase.aspx?name=1010752

Scope
1. The pipeline guide provides a snapshot of the global therapeutic landscape of Insomnia (Central Nervous System).
2. The pipeline guide reviews pipeline therapeutics for Insomnia (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
3. The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
4. The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
5. The pipeline guide reviews key companies involved in Insomnia (Central Nervous System) therapeutics and enlists all their major and minor projects.
6. The pipeline guide evaluates Insomnia (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
7. The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
8. The pipeline guide reviews latest news related to pipeline therapeutics for Insomnia (Cardiovas

Table of Contents:
1. Global Markets Report Coverage
2. Insomnia - Overview
3. Insomnia - Therapeutics Development
4. Insomnia Pipeline Overview
5. Insomnia Pipeline by Companies
6. Insomnia Pipeline by Universities/Institutes
7. Insomnia Products under Development by Companies
8. Insomnia Products under Development by Universities/Institutes
9. Insomnia - Therapeutics Assessment
10. Assessment by Target
11. Assessment by Mechanism of Action
12. Assessment by Route of Administration
13. Assessment by Molecule Type
14. Insomnia - Companies Involved in Therapeutics Development

About Us:
Reportnreports.com provides market research reports to industries, individuals and organizations with an objective of helping them in their decision making process. Our library of 500,000+ industry & country research reports covers 5000+ micro markets. This comprehensive collection of market research reports include market share analysis, industry analysis, information on products, countries, market size, trends, business research details and much more.

Contact Us:
Ritesh Tiwari
2nd Floor, Metropole,
Bund Garden Road,
Pune – 411001,
India.
Tel: + 1 888 391 5441
E-mail: [email protected]